Cancer Cell 2017-07-10

MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer

Chi V. Dang

Index: 10.1016/j.ccell.2017.06.006

Full Text: HTML

Abstract

In this issue ofCancer Cell, Singh and colleagues report a role for MUC1-induced HIF expression in rewiring ribose synthesis, which drives pyridimine production as a possible resistance mechanism to gemcitabine, adding to complexity and multiple paths to resistance.

Latest Articles:

HDAC Inhibitors Finally Open Up: Chromatin Accessibility Signatures of CTCL

2017-07-10

[10.1016/j.ccell.2017.06.008]

Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and CHAARTED Studies

2017-07-10

[10.1016/j.ccell.2017.06.007]

Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

2017-07-10

[10.1016/j.ccell.2017.06.005]

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

2017-07-10

[10.1016/j.ccell.2017.06.004]

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

2017-07-10

[10.1016/j.ccell.2017.06.003]

More Articles...